HERB CROSS
CIK 1230721 · Chief Financial Officer · last filed 2026-01-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$123.6K
Companies
8
Total Filings
48
Lifetime Open-Market Net
-$513.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JSPRW | Chief Financial Officer | — | $0.01 | — | $0 | 5 | 2026-01-05 |
| Atreca, Inc. (BCEL) Delisted | Chief Financial Officer | 72,817 | $0.15 | $10.9K | -$18.8K | 8 | 2023-08-04 |
| Apexigen, Inc. (APGNW) Delisted | Director | — | $0.03 | — | $0 | 1 | 2022-10-03 |
| ARMO BioSciences, Inc. (ARMO) Delisted | Chief Financial Officer | — | — | — | $0 | 1 | 2018-06-22 |
| HUMANIGEN, INC (KBIO) Delisted | Chief Financial Officer | — | — | — | $0 | 14 | 2015-11-10 |
| AFFYMAX INC (AFFY) Delisted | Chief Financial Officer | 21,370 | — | — | -$495.0K | 6 | 2013-02-01 |
| FACT | VP of Finance/Prin Acctg Off | 11,602 | $10.65 | $123.6K | $0 | 7 | 2010-04-21 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Corp Controller/Prin Acctg Off | 5,031 | — | — | $0 | 4 | 2008-09-17 |
Recent Filings · Page 5 of 5
48 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-09-15 | FACT | Tax (F) | −1,379 | -$22.5K | EDGAR |
| 2009-08-10 | FACT | Grant (A) | +4,500 | $0 | EDGAR |
| 2009-04-06 | FACT | Grant (A) | — | $0 | EDGAR |
| 2009-01-27 | FACT | Mixed | +14,827 | -$1.5K | EDGAR |
| 2008-09-17 | PDL BIOPHARMA, INC. (PDLI) Delisted | Tax (F) | −625 | -$6.8K | EDGAR |
| 2007-12-20 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +1,000 | $0 | EDGAR |
| 2007-09-17 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +3,500 | $0 | EDGAR |
| 2007-08-17 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 41–48 of 48
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.